001in my capacity. The fact that I'm from Barbados, one of the WHO's smallest member states, sends a signal as to how important as to how important the WHO and global public health is to my small island state. Multilateralism and multilateral institutions are crucial to us all, but especially for the most vulnerable. This Executive Board meeting at a time where the primacy of global health governance is under severe scrutiny, multilateralism, as we know it, particularly in the global health sphere, is under threat. An unrelenting and unforgiving climate crisis, heightened geopolitical tensions, as well as conflict within and among countries, who is real and lasting risk to global health. Misinformation and disinformation on public health challenges the credibility of the WHO and its ability to build consensus on global health policy and the effective implementation of public
002health policies at the national level. Misinformation can have serious consequences on our populations who look to the media and increasingly social media for facts. We fail our people when we do not provide accurate information. We are meeting at a time where financing the WHO's global health agenda has demanded our full attention and has hastened the need for us to be creative in developing innovative means of financing. From broadening the donor base and reducing our dependence on a limited number of traditional donors to challenging the Secretariat to raise more resources through new avenues. We must mobilize financing in a fiscally conservative global environment. Importantly, we need to agree to the next increase of assessed contributions for 2026-2027 by 20%. Without this increase, the objective of raising assessed contributions to cover 50% of WHO's base budget by
0032030 will not be guaranteed. We all recognize the need for reform. I must acknowledge the progress made thus far by the WHO Secretariat and the discussions under the guidance guidance that the member state leads on governance reform. Colleagues, a compromised or fragmented global health system not only costs lives, but also poses one of the greatest threats to the global economy and global security. The issues before us and the decisions that we make this week will be consequential to the future of WHO as an institution, to global health governance and to the health of billions of people across the world. We must therefore focus on concrete deliverables that redound to what we envision the WHO to be in the future. An organization that is fit for purpose, sustainably financed, and agile enough to address its program
004work and any health emergencies that may arise. I was delighted to exchange views with many of you during yesterday's informal meeting of the board. We discussed critical issues confronting the WHO and agreed that whilst the matters before us may not be simple, they are utmost importance to the future of the WHO. I therefore trust our collective resolve to support WHO's functions and to to develop viable solutions for sustainable financing. I will now present a summary of the informal meeting. I would like to take this opportunity to report to you on yesterday's informal meeting of the Executive Board, which I just mentioned. We met for a full day in a relaxed format and at the outset we considered the outcomes of the PBAC last week and expressed our appreciation to the PBAC chair, Dr. Catherine Loftus,
005for her excellent stewardship. We also acknowledged that WHO is in a challenging phase after the announcement by the United States of its intention to withdraw from the organization and recognized important role of the board in guiding the Secretariat during this time. To this end, we rolled up our sleeves and delved into two main topics. First, we turned to the matter of governance reform and considered the member state led governance reform process and the proposal that member states discussed in the coming months a more sustainable model for governance reform. We expressed our deep appreciation for the work of the member state leads on governance reform and agreed it would be important to maintain the momentum on this important issue. We also reflected on agenda management and resolution management, paying particular attention to the financial implications of
006draft revolutions resolutions, including those that the board is expected consider at its 156th session. Furthermore, we highlighted the challenge of participating meaningfully in the recent negotiations of some 20 or so draft resolutions and discussed whether there might be a mechanisms for addressing such a large volume. For example, we discussed how in instances where the objective of a resolution is to raise awareness and for advocacy rather than to create new work streams, other instruments such as side events might be more prudent. While noting that proposing resolutions to the governing bodies is the prerogative of member states, we recognize that future proposals for resolutions could be informed by gap and risk risk analysis, clear identification of costs and possible funding sources, priorities as expressed at the country level, and an analysis of linkages to the 14th general
007program of work. It was also pointed out that the officers of the board might have a role to play in gathering information and having informal discussions about proposals. We discussed how the board might consider requesting the Secretariat to prepare for this week an information document providing an overview of the cost implications and options for addressing the potential challenge of additional activities for WHO in view of the current concerns about financing. In addition, we may wish to request that the Secretariat prepare paper for our May meeting identifying reforms that have been implemented and others that are needed to help us move forward. Next, we turn to the strategic matters. We discussed the development of the proposed program budget 2026-2027 and the three options which were presented in light of the expected decrease in financing. We noted
008the PBAC's proposal to decrease the base segment of the program budget for 2026-2027 to US $4.9 million, which we will be discussing later today. We also recognized the PBAC's support for the 20% increase in assessed contributions and how such an increase constitutes a logical step in the sustainable financing journey. This would follow on from WHO's first investment round, which was launched last year. Several possible approaches to innovative financing were discussed, including a WHO endowment fund. There was a common understanding that WHO is in a difficult situation and that our consideration of the budget and our WHO reform could not be business as usual. In response, WHO would pursue the twin goals of resource mobilization and efficiency gains. In our discussions, we highlighted the need for WHO to improve its communications activities, including in country offices.
009We also noted that other avenues would also be explored in order to broaden the donor base and improve the quality and sustainability of funding. All in all, we had a very positive day of exchange and getting to know each other better. I would like to thank the members of the board for coming out on a Sunday afternoon ahead of a week and a half of intense discussions, as well as for their frank and active engagement that will surely contribute positively to the work before us. It is my pleasure to welcome all Executive Board members and their alternates and advisers. I would also like to cordially greet representatives of member states, observers, the United Nations, various United Nations bodies and specialized agencies, other intergovernmental organizations and non-state actors in official relations with WHO, whose participation is
010further evidence of the close relations between WHO and these organizations. Finally, welcome to our Secretariat colleagues who are following and supporting the deliberations at this of this meeting. Let us now turn to the consideration of the agenda for this session of the board. In accordance with the provisions of the rules of procedure, the board has before it this session's provisional agenda contained in documents EB156/1 and EB156/1 annotated. In accordance with rule eight of the rules of procedure, the executive board the offices of the board with the director general met with the director general on 8th of October, 2024 to review the draft provisional agenda of the 156th session of the board that had been circulated to member states on July the 2nd, 2024. Proposals received from member states by the deadline of the 24th of
011September 2024 were considered and the provisional agenda was agreed by the offices of the board. At this time, I would like to propose the deletion of the following agenda items as I understand they are not needed. Sub-item 23.3, scale of assessment 2026 to 2027, sub-item 23.4, amendments to the financial regulations and financial rules, sub-item 26.2, independent expert oversight advisory committee membership renewal. These items are included systematically on the agenda in case they are needed. In this instance, they are not needed. May I take it that the proposals are acceptable? I see no objection. It is so decided. Are there any further comments on the provisional agenda? I see none. Thank you. The agenda is therefore adopted. I give the floor to Paul Poland. Thank you, Mr. Chair, Director General, members of the executive board, dear
012colleagues. The European Union works closely with the World Health Organization on a wide range of subjects both within the European region and on a global level. As agreed in the exchange of letters of the year 2000 between the WHO and the European Commission concerning the consolidation and intensification of cooperation and without prejudice to any future conclusion of a general agreement between the WHO and the European Union, the European Union delegation attends the meetings of the executive board as observer. As in previous EB meetings, we ask the executive board to kindly agree that the European Union delegation is also invited to attend and participate without vote in the deliberations of the meetings of its committees and subcommittees, drafting groups or other subdivisions thereof, addressing matters falling within Union competence in the 156th session of the executive
013board. I thank you. Thank you very much. I understand that this is the usual practice in the executive board. Dear colleagues, do you agree to proceed in this way? I see no objections. Thank you. As you know, the EB156 has a heavy agenda with 47 items and sub-items and approximately 38 draft resolutions and decisions to be considered. All participants are encouraged to be concise when taking the floor. I would like to request that statements focus on the guiding questions provided in the reports prepared by the secretariat. We will also have these guiding questions projected on the screen during our discussions. With that in mind, EB members are encouraged to limit their interventions to 3 minutes. Individual statements by all member states not represented on the board and associate members will be limited to 2 minutes.
014Statements by observers, invited representatives of United Nations agencies and other participating intergovernmental organizations and non-state actors in official relations with WHO will be limited to 1 minute. Regional and group statements will be limited to 4 minutes. I would like also to inform you that as agreed, constituency statements by non-state actors in official relations will continue during this meeting and will be provided on the following selected agenda items. Item six, universal health coverage, item 12, health and care workforce, item 15, WHO's work in health emergencies, item 18, universal health and preparedness review, item 22, climate change and health, item 24.2, governance reform, involvement of non-state actors in WHO's governing bodies. Constituency statements delivered on behalf of a group of several NSAs will be limited to 3 minutes and will be delivered after all EB members intermingled
015throughout the discussion and among statements by member states not represented on the board. In order to help speakers observe the time limits, I've asked the secretary to keep in place some of the innovations introduced by the PBAC chair last week. Liam needs to provide a chime when the traffic lights change from green to yellow and again when it changes from yellow to red. Though I don't anticipate the need to cut anyone's microphone, there's a possibility of doing so with any statements that run well beyond the time limits. When we move to the agenda items considered last week by PBAC, I propose to build on the good work of that committee by focusing our discussion on the PBAC report and its recommendations rather than having another full discussion of each of the documents. May I take
016it that these proposals are acceptable? I see no objection. It is so decided. Let us now review the preliminary daily timetable contained in document EB156/the eighth/two. It is proposed that the board meet this morning until 12:30 and then this afternoon from 14:30 hours to 17:30 hours. On each of the remaining days, I propose that we meet from 10:00 to 1:00 and from 2:30 to 5:30. This morning, following the conclusion of item one, the board will consider item two, report by the director general, which will be followed by item three, report of the regional committees to the executive board, and item four, report of the program budget and administration committee of the executive board. The board will then turn to to item 24, management and governance matters, and take up sub-item 24.2, governance reform, which includes
017five bullet points. I propose that we discuss the first three bullet points together and then have a separate discussion on the last two bullets. Following the discussion on governance reform, I propose that we take up sub-item 23.1, finance and implementation of the program budget 2024 to 2025, followed by sub-item 23.2, proposed program budget 2026 to 2027. Tomorrow, Tuesday, the 4th of February at 10:00 a.m., I propose that the board take up pillar one items. In the afternoon, we will return to item 27, staffing matters, and consider items 27.1 and 27.2 in a private meeting concerning the appointment of the regional director for Africa and Europe regions, respectively. I would like to remind you that the private meeting is held in compliance with rule seven of the rules of procedure of the executive board, which means
018that members of the board, their alternates and advisers, can attend and that member states not represented on the board and associate members can send one representative each without the right to participate, and that the secretary's attendance will be limited to essential staff only, and that no official record shall be made. Do I take it that the board agrees with these proposals? As I see no objection, it is so decided. When delivering statements, I would like to remind delegates to speak at a moderate speed that allows for its interpretation and ensures their message is conferred clearly and accurately. Please send a copy of your written statements in advance to the email address [email protected] at least 30 minutes in in advance of delivery. This does not prevent you from making changes on your on delivery, but will
019facilitate clarity and accuracy in all languages. If you would like your statement to be posted on the WHO website or if you have a longer statement with supplementary information you would like to share, you may send it to the email address [email protected]. Please remind be reminded that written statements will not be included in the summary record of the meeting. Are there any comments before we proceed? I see none. Thank you. Finally, I would like to remind board members that in accordance with rule 32 of the EB rules of procedure, proposals for resolutions or decisions to be considered by the board relating to items of the agenda should be introduced at least 15 days before the opening of the session and may in any event be introduced not later than the close of the first day
020of the session. And these should be sent to governance unit at who.int by 6:00 p.m. today. Before moving to the next item, I understand that we will receive comments from the office of the United Nations Secretary-General delivered by Deputy Secretary-General Amina Mohammed. Thank you. Excellencies, ladies and gentlemen, my dear brother Tedros, as we gather at a defining moment for global health in the world, the world faces escalating threats on many fronts, geopolitical tensions, deep inequalities, climate shocks, and the erosion of multilateralism. In these trying times, the entire United Nations stands in support of the World Health Organization and its mandate to promote, provide, and protect health in every country around the globe. Global health needs are expanding. Conflicts, disease outbreaks, and demographic shifts which is stretching diminished resources to their limit. Whether responding to deadly
021disease outbreaks like Ebola, Marburg, cholera, or measles, in violent conflict or disasters, mobilizing in humanitarian crises, or in the face of COVID and other pandemics, WHO is there, deploying life-saving resources, coordinating international response, and providing its unparalleled technical expertise where it is needed most. Excellencies, WHO's role extends far beyond crises and emergencies. As the world's leading public health authority, it is the guardian of global health, setting standards, coordinating international responses, and ensuring that people everywhere, no matter where they live, have access to the care that they need. Yet, we know that there is still much more to do. The outcomes of the 2023 General Assembly high-level meetings on universal health coverage, antimicrobial resistance, and pandemic preparedness have strengthened our collective resolve. And in September, member states came together and agreed on the pact for the
022future, reaffirming that investing in health is investing in people, economies, and the planet. Now, the real test is implementation. This is where the UN development system, including our resident coordinators and our UN country touring teams, play a critical role. Turning global commitments into action on the ground, in communities, and in the lives of those who need it most. With the 2030 deadline for Sustainable Development Goals fast approaching, our resolve must be stronger than ever. This is the decade of action, and the countdown is on. Health is the foundation of sustainable development. Without strong health systems, we cannot end poverty, advance gender equality, or protect our planet. There is no option B. Investing in health and in a resilient WHO is an investment in a prosperous, healthy, and a safer world for today and generations to
023come. I wish you fruitful deliberations. Thank you. Thank you. This concludes our consideration of agenda item one. Let us now consider a consider item two of our agenda. Report by the Director-General contained in document EB156/2. It is now my pleasure to give the floor to the Director-General, Dr. Tedros Adhanom Ghebreyesus. Dr. Tedros, you have the floor. Thank you, Chair. Honorable Chair, Dr. Jerome Walcott, honorable ministers, dear colleagues, and friends. Good morning. Happy New Year. And welcome once again to your WHO headquarters. As you know, for me, 2024 ended with a narrow escape in Yemen when the airport in Sana'a was attacked while I was there waiting for my flight home. I think starting your year with that is not funny. And I want to express my heartfelt gratitude to each of you who reached out
024with calls and messages of support. Your kindness provided comfort during such a frightening moment. My email, my WhatsApp, all actually was um you know, my accounts were flooded. So, that just wanted to express my gratitude to you. And also, I thank God for uh sparing me. I was fortunate, but it was a reminder of the threat that so many people live with every day in dangerous situations around the world, including many of my WHO colleagues, the UN colleagues, and humanitarian at large. For them and for WHO as a whole, 2024 was a year of significant challenges. It was also a year of significant milestones. At the World Health Assembly in May, member states approved our new global health strategy, the 14th General Program of Work, with an ambitious target to save 40 million lives over
025the next 40 years. Over the next four years. You also approved a historic package of amendments to the International Health Regulations. And you agreed to conclude negotiations on the WHO Pandemic Accord in time for next World Health Assembly. In November, we also concluded the first WHO investment round, which helped to mobilize half of the resources we need to implement GPW14 over the next four years. And in December, I joined President Macron to officially open the WHO Academy in Lyon, a major step towards making WHO an organization that delivers an impact in countries. There were also many achievements to celebrate in our threefold mission, promote, provide, and protect health. First, our mission to promote health and prevent disease by addressing its root causes. As you know, non-communicable diseases account for seven of the top 10 causes
026of death globally, including cardiovascular diseases, diabetes, cancer, and chronic respiratory disease. One of WHO's key focuses is addressing the risk factors for NCDs in the food people eat, the air they breathe, the roads they use, and the products they consume, including tobacco, the world's leading cause of preventable death. This month marks the 20th anniversary of the entering into force of the WHO Framework Convention on Tobacco Control. Over the past two decades, thanks to the WHO FCTC and the MPOWER technical package that supports it, smoking prevalence has dropped by 1/3 globally. Last year, Georgia, Lao PDR, and Oman introduced plain packaging on tobacco products. With WHO support, Vietnam prohibited e-cigarettes and heated tobacco products. And through the partnership in the Tobacco-Free Farms Initiative, we have supported more than 9,000 tobacco farmers in Kenya and Zambia to
027shift away from growing tobacco to growing high iron beans. Another key focus is addressing the drivers of diseases in the diets people eat. In 2024, Lebanon, Mauritius, and Nepal passed best practice policies on trans fat elimination. 34 countries have now joined the acceleration plan to stop obesity, representing 1/3 of the global population with obesity. We published a new guideline on wasting and supported 14 countries with the highest burden to implement it. We're also seeing progress in preventing deaths and injuries from drowning, road traffic crash, and violence. We're integrating behavioral science into more areas of our work. And we continue to support countries to build climate-friendly and climate-resilient health systems. We have mobilized 150 million US dollars to support low-and-middle-income countries to protect the health of their people from climate risks. And at COP 29 in
028Azerbaijan, we signed an agreement to keep health at the heart of climate negotiations. Second, our mission to provide health by expanding equitable access to health services. As you know, more than half the world's population lacks access to one or more essential health services. And 2 billion people face financial hardship by paying for care out of their own pockets. To address these gaps, we're working through the UHC partnership to support 125 countries in all six regions on the road towards universal health coverage. Last year, we provided support to 28 countries to develop packages of services for universal health coverage, including eight countries with humanitarian crisis. And we're supporting countries to expand health services to refugees and migrants. Ireland and Panama integrated refugee and migrant health into national health care plans. Uganda provided a comprehensive health package
029to 1.6 million refugees. And Colombia issued health insurance cards to 1.5 million migrants. Just as we work to expand access to health services, so we are working to expand access to medicines and health products and to strengthen regulatory authorities around the world. We recognized Egypt, India, Rwanda, Senegal, and Zimbabwe for achieving or maintaining maturity level three for regular regulatory oversight of medicines and vaccines. As WHO-listed authorities, making them regulators of reference that meet internationally recognized standards and practices. We have now list 36 regulators since we launched the program three years ago. In 2024, we prequalified 87 medicines and other products and performed more than 150 inspections of manufacturing sites. We launched a new platform with information on 2,000 types of medical devices which countries are using to select devices for health interventions, procurement, or national
030reference lists. We issued five alerts on substandard and falsified medicines. And we selected 481 nonproprietary names for active pharmaceutical ingredients. The international nonproprietary name program is one of those things that WHO does that no one else can do and that every that very few people know about but is relevant to all countries. Standardized standardized names for pharmaceutical ingredients are absolutely essential for patient safety, global trade, tracking and tracing medicines, combating counterfeits, increasing access, research, and more. It's not glamorous, but someone has to do it. And that someone is WHO. And it's helping to increase access to life-saving tools, including vaccines. On antimicrobial resistance, the UN high-level meeting on AMR resulted in strong commitments and targets. The number of countries reporting data on antimicrobial resistance on antimicrobial use to WHO has tripled from 36 in 2021
031to 98 in 2024. And countries are adapting our our aware recommendations on antibiotics. Nepal, for example, has banned the use of antibiotic combinations that WHO classifies as not recommended. We also supported full implementation of surveillance for antimicrobial resistance gonorrhea in 13 countries. In Cambodia, implementing WHO guidelines reduced gonorrhea treatment failure from 11% to zero. We also developed the first guidance on wastewater and solid waste management for manufacturing of antibiotic antibiotics. Already, we have trained inspectors in 52 member states, and the AMR industrial alliance updated its standard to align with WHO guidance. Last year, we celebrated the 50th anniversary of the expanded program on immunization. When EPI was launched in 1974, less than 5% of the world's children were immunized. Today, that figure stands at 83%. I would like to pause and ask you one question
032here. Do you know the director general who started the EPI program? No? It's Mahler. So, I just wanted to underline that. EPI has been the single biggest contributor to infant and child survival globally, preventing 154 million deaths, an average of 8,000 a day for 50 years. And we continue to support countries to introduce new vaccines to save lives. In 2024, four new countries introduced HPV vaccines. Niger and Nigeria became the first countries to implement the new Men5CV vaccine meningitis vaccine. We prequalified a new vaccine against dengue. And we supported the rollout of more than 12 million doses of malaria vaccine in 17 countries in Africa. Meanwhile, we're living in a golden age of disease elimination with more and more countries liberating their people from malaria, trachoma, leprosy, lymphatic filariasis, and more. Last year, we certified
033seven countries for the elimination of neglected tropical diseases. Brazil, Chad, India, Jordan, Pakistan, Timor-Leste, and Vietnam. And just last week, we certified Guinea for the elimination of human African trypanosomiasis and Niger for the elimination of onchocerciasis. Last year, only 11 human cases of guinea worm disease were reported from just eight villages in Chad and South Sudan. Ghana approved a new treatment for river blindness, which was developed through two decades of collaboration between TDR, researchers, WHO country offices, and medicines development for global health. We also certified Cabo Verde and Egypt as malaria-free, and already this year, Georgia has reached the same status. Belize, Jamaica, and St. Vincent and the Grenadines were validated for the elimination of mother-to-child transmission of HIV and syphilis. And we validated Namibia for being on the path to elimination of mother-to-child transmission
034of HIV and hepatitis B. For the first time, TB treatment coverage has now reached 75% globally. 79 countries have achieved at least a 20% reduction in incidence, and 43 countries have achieved at least a 30% 35% reduction in TB deaths. And on mental health, we're working with UNICEF in 13 countries in all six regions, reaching 270,000 children, adolescents, and caregivers caregivers with care services. On maternal and child mortality, progress is less encouraging. After substantial improvements during the MDG era, progress has stalled. We continue to work with member states to identify the barriers and to give them the tools to overcome them. For example, to increase uptake of family planning practices, we developed a protocol to rapidly assess to rapidly assess bottlenecks, which 27 countries are now implementing. We published a new guideline on neonatal sepsis,
035and we're supporting countries to implement it. And we launched guidance on midwifery models of care, which has been shown to reduce emergency cesarean section, preterm birth rates, and admissions to neonatal intensive care. Over 90 countries have developed acceleration plans to reduce maternal and newborn mortality and prevent stillbirths. Tanzania opened 13 new care units for newborns, while Pakistan, Ghana, Sierra Leone, and Malawi are also making progress. We have come a long way on maternal and child mortality, but we still have a long way to go to reach the SDG targets. For World Health Day this year, we have chosen maternal health as our theme to draw attention to the need for all countries and partners to work together and prevent this preventable diseases. Now, to the third pillar of our mission, supporting countries to protect health
036by preventing and responding rapidly to health emergencies. In 2024, we responded to 50 graded emergencies around the world, conflicts, outbreaks, natural disasters, and more. This included delivering $48 million worth of supplies to 78 countries. We helped bring cholera outbreaks under control in 27 of 33 affected countries, leaving only six in an acute phase. With WHO support, Rwanda controlled an outbreak of Marburg virus disease. And we as we speak, we're responding to outbreaks of Marburg in Tanzania and Ebola in Uganda, where Deputy Director-General Dr. Mike Ryan has traveled to oversee the response. And as you know, in August last year, I declared a public health emergency of international concern over the outbreaks of mpox in the DRC and other countries in Africa. Although the number of reported cases has been stabilizing in DRC, the worsening security
037situation has led to many patients leaving treatment centers, increasing the risks of high transmission. In response to the outbreak, WHO gave emergency use listing to the first mpox vaccines and tests, and established an access and allocation mechanism, which coordinated donations of 6 million vaccine doses across 15 countries. About 500,000 doses have been delivered, and a further 1.7 million doses will soon be available. We also provided supplies to laboratories in 136 countries to quality assure their capacity for diagnosing mpox. About 70,000 people have been vaccinated, mainly in DRC, and resource limitations in the affected countries, which face multiple competing health priorities, have limited the speed and scale of vaccination. The other main part of WHO's emergency response work last year was responding to conflicts and insecurity in Gaza, Haiti, Lebanon, Sudan, Ukraine, and elsewhere. We're very
038pleased to see that the ceasefire agreement in Gaza is holding, and we very much hope it becomes a lasting peace. Our priorities are to meet acute health needs, support the operation of hospitals and primary care facilities, and transport patients within out within and out of Gaza for specialized care. Since the ceasefire began, WHO has sent 63 trucks with supplies, and 30 more should arrive in the coming days. We provide 60% of all the medical supplies and 100% of the fuel for hospitals and emergency medical facilities. In total, during the conflict, we coordinated the deployment of 52 emergency medical teams from 26 organizations, which conducted over 2.4 million medical consultations, performed more than 36,000 emergency surgeries, and treated almost 86,000 trauma cases. And together with our partners, we negotiated a humanitarian pause and prevented a resurgence
039of polio by vaccinating more than 550,000 children. We can only hope that 2025 also brings an end to the conflicts in Sudan and Ukraine. In Sudan, an estimated 32,000 people have been killed, 30% of the population is displaced, and 20 million people need humanitarian aid. I visited Sudan in September, where I saw the effects of civil war and met people who are paying the price. The following week, I was in Chad, where I traveled to the border town of Adré, and met some of the 900,000 Sudanese refugees who fled seeking security and food. And they're just a fraction of the 122 million people globally who have been forced to flee their homes. In Gaza, Lebanon, Sudan, Ukraine, and elsewhere, we continue to see attacks on health care, which are becoming a new normal of conflict.
040Last year, we verified more than 1,500 attacks on health care in 15 countries and territories with 932 deaths and 1,767 injuries. It's frustrating that almost no one is ever held to account for these violations of international law. So, with our partners, we launched a new report last year with nine recommendations for bringing to account those who perpetrate attacks on health care. We urge member states to implement these recommendations. Of course, responding to emergencies is just one part of our work. In response to the lessons learned from COVID-19, WHO has strengthened its work in every dimension of emergency prevention, preparedness, and response. Every day, we scan the world for public health threats. Last year, we assessed more than 1.2 million potential signals. And through the WHO Hub for Pandemic and Epidemic Intelligence in Berlin, we're supporting
041countries to strengthen their capacities in genomic surveillance. The International Pathogen Surveillance Network, established in 2023, now includes 230 organizations in 85 countries. We supported 19 countries to complete joint external evaluation, with another 21 scheduled for this year. And three countries completed pilot studies of the Universal Health and Preparedness Review. In addition to these general preparedness activities, we are also supporting countries to prepare for specific threats, including Ebola. Ebola outbreaks are often fueled by nosocomial transmission. So, with Gavi, we vaccinated 150,000 health workers in six countries against Ebola, the first time this has happened outside of an outbreak response to prevent any out any future outbreak. We also supported the vaccination of 53 million people against yellow fever in five countries. And we have monitored carefully the concerning spread of avian influenza among dairy cattle in
042the United States. Through the global influenza surveillance and response system GISRS, we facilitated sharing of more than 100 zoonotic flu samples with WHO collaborating centers last year and uploaded 525 influenza genetic sequence to publicly available databases. And we recommended nine new zoonotic candidate vaccine viruses available globally to manufacturers to produce vaccines in case of an influenza pandemic. Honorable ministers, dear colleagues and friends, all of this work to promote, provide and protect health is supported by our efforts at all three levels of the organization on the fourth and fifth piece of GPW 14. To power and perform for health through science, digital technologies, data and our ongoing transformation. Last year, we conducted a review of our transformation to see what has worked and what has not. Based on the review, we have re-prioritized transformation and aligned
043it with priorities of GPW 14. One of the success of transformation has been the establishment of the science division. WHO's normative standard setting work is its bread and butter, as you know, and the science division is helping us make sure we give member states the highest quality evidence-based advice as fast as possible. Last year, there were 65 million downloads of WHO publications, guidance and other materials. We launched important new guidelines on avian influenza, artificial intelligence, tobacco cessation, mpox diagnostics and so much more. Starting this year, we're aligning our guide guidelines and normative work with pre-qualification, meaning we will pre-qualify a product and issue guidelines on how to use it at the same time. This will speed up equitable access to proven interventions and increase investments from the public and private sectors as the systems will
044become more transparent and predictable completed within a 12-month period. The first product under this new process will be lenacapavir, an exciting exciting new medicine for the treatment and prevention of HIV. Although a true HIV vaccine remains elusive, lenacapavir is the nearest thing we have to it. A new injectable antiretroviral taken every 6 months that has been shown to prevent almost all HIV infections in those at risk. We have initiated the guideline and pre-qualification processes in parallel, which will support the rapid rollout of this product, which we expect in the first half of this year. Another success of transformation has been our increased focus on digital health, which will underpin health systems in every country in the very near future. Last year, the global digital health certification network enabled Oman, Indonesia and Malaysia to issue 250,000
045international patient summaries for 2024 Hajj pilgrims, supporting emergency care for 78% of scanned records. The network now covers 82 countries, benefiting nearly 2 billion people. And I thank you for the support in this. Another key element of our transformation has been our focus on data. We created the World Health Data Hub to make health data available to anyone, anytime using digital technologies, including artificial intelligence. Every country in the world now accesses the hub, which is a secure and standardized pathway to increased transparency, accountability and progress. Honorable ministers, dear colleagues and friends, as you know, 2 weeks ago, President Donald Trump signed an executive order announcing his intention to withdraw the United States from WHO. We regret the decision and we hope the US will reconsider. We would welcome constructive dialogue to preserve and strengthen the
046historic relationship between WHO and the USA that helped bring significant impacts like the eradication of smallpox and I can give you a long list. The executive order gave four reasons for the decision to withdraw from WHO. First, it says that WHO has failed to adopt urgently needed reforms. As this board is aware, over the course of the past 7 years, under the guidance and governance of member states, WHO has implemented the deepest and most wide-ranging reforms in the organization's history. The WHO transformation has touched every part of our work, our strategy, operating model, processes, partnerships, financing, workforce and culture. We have also taken action on the recommendations of the Agile States member states task group. We have implemented 85 of the 97 reforms proposed in the Secretariat implementation plan on reform or ORSIP. And we're
047implementing the recommendations of the Action for Results Group led by WHO representatives to strengthen our country offices. For us, as we always say, change is a constant. And that's what our member states told us when we started the reform. Change is a constant. We believe in continuous improvement. And we would welcome suggestions from the United States and all member states for how we can serve you and the people of the world better. So, although we're doing a lot of reform, but additional is welcome. Second, the order says that WHO demands unfairly onerous payments from the US out of proportion with what other countries contribute. Member states understand how assessed contributions are calculated. And you know, some countries choose to make higher voluntary contributions than others. Addressing the imbalance between assessed assessed and voluntary contributions and
048reducing WHO's overall reliance on a handful of traditional donors has been one of the major areas of transformation. Because when we started the transformation, reliance on few traditional donors was identified as at a risk. And we have decided then, 7 years ago, to broaden the donor base. Last week, the PBAC recommended the next 20% of increase in assessed contributions and we asked this board to endorse that recommendation. This is a critical element of our long-term plan to broaden our donor base and will, over the long term, reduce the burden of financing for tradition from traditional donors, including the US. We therefore continue to seek the support and engagement of all member states, including the US, for our shared vision to put WHO on a more sustainable financial footing. Third, the order refers to WHO's alleged
049mishandling of the COVID-19 pandemic and other global health crises. Last week marked 5 years since I declared a public health emergency of international concern. On the 30th of January 2020, 2020 and at the same at the at the time outside of China, there were fewer than 100 reported cases and no reported deaths. On New Year's Eve 2019 and New Year's Day 2020, when much of the world was on holiday, WHO was not. I think you remember that. From the moment we picked up the first signals of viral pneumonia in Wuhan, we asked for more information, activated our emergency incident management system, alerted the world, convened global experts, and published comprehensive guidance for countries on how to protect their populations and health systems all before the first death from this new disease was reported in China
050on the 11th of January 2020. Of course, there would be challenges and weaknesses and there have been multiple independent reviews of the global response to COVID-19 with more than 300 recommendations to address the challenges or the weaknesses. In response to those recommendations, WHO and our member states have taken many steps to strengthen global health security, the pandemic fund, the WHO hub for pandemic and epidemic intelligence, the mRNA technology transfer hub, the global training hub for biomanufacturing, the global health emergency core, the interim medical countermeasures network, and more. So, all this has been established based on the lessons learned. And as I mentioned earlier, member states have committed to concluding negotiations on the pandemic agreement in time for this year for this year's World Health Assembly. Finally, the executive order says WHO has an inability to
051demonstrate independence from the in appro- inappropriate political influence of our member states. As a UN agency, WHO is impartial and exists to serve all countries and all people. Our member states ask us for many things and we always try to help as much as we can. But when what they ask is not supported by scientific evidence or are contrary to our mission to support global health, we say no politely. And you have seen me doing that many times. As member states know, that's what we have done on several occasions to countries of all income levels in all regions. Honorable ministers, dear colleagues, and friends, even before the US announcement, WHO is facing a shortfall due to the economic difficulties that many countries are facing. For many months, the regional directors and I, with the support
052of senior management, had been working with twin strategic goals to mobilize new resources and to tighten our belts. The US announcement has made the situation more acute and we have announced a set of measures with immediate effect to protect our work on workforce to the greatest extent possible. We're conducting a strategic alignment of resources with activities. We're freezing recruitment except in the most critical areas. We're significantly reducing travel expenditure and we're looking to renegotiate major procurement contracts and reduce capital investments. More measures will be announced in due course. Our main objective is to protect our most important asset, our people. The dedicated, talented professionals who today are working around the world to help the people we serve to breathe clean air, eat healthier diets, drink safer water, and use safer roads. And they're working to
053help people get the safe, quality health services and products they need where and when they need them without worrying about what it will cost. And they're working to stop outbreaks and deliver life-saving care in the most difficult and dangerous situations. In short, they're committed to promoting, providing, and protecting health. And I'm proud to call them my colleagues. And together, we remain committed to the vision that you, our member states, had almost 77 years ago. The highest attainable standard of health, not as a luxury for some, but a right for all. I thank you. Thank you, Dr. Tedros. The floor is now open for discussion. Kindly raise your nameplate should you wish to take the floor. You said Cameroon. Cameroon. You said Cameroon. Sao Tome. Here. I give the floor to Brazil.